Morgan Stanley
NUTX

Morgan Stanley’s Nutex Health NUTX Stock Holding History

Morgan Stanley’s Portfolio NUTX Stock Details NUTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.04M Sell
42,498
-15,142
-26% -$1.86M ﹤0.01% 4287
2025
Q4 		$9.49M Sell
57,640
-63,161
-52% -$8.38M ﹤0.01% 3659
2025
Q3 		$12.5M Buy
120,801
+89,493
+286% +$8.78M ﹤0.01% 3345
2025
Q2 		$3.9M Buy
31,308
+29,434
+1,571% +$3.8M ﹤0.01% 4258
2025
Q1 		$88.1K Buy
1,874
+1,215
+184% +$59.3K ﹤0.01% 6076
2024
Q4 		$20.9K Buy
+659
New +$18.8K ﹤0.01% 6559
2024
Q3 		– Sell
-451
Closed -$2.68K – 8000
2024
Q2 		$2.68K Sell
451
-33
-7% -$238 ﹤0.01% 7012
2024
Q1 		$6.97K Sell
484
-390
-45% -$7.85K ﹤0.01% 6809
2023
Q4 		$23.6K Sell
874
-10
-1% -$312 ﹤0.01% 6597
2023
Q3 		$26.9K Sell
884
-425
-32% -$20.5K ﹤0.01% 6395
2023
Q2 		$82.8K Sell
1,309
-402
-23% -$34.5K ﹤0.01% 6025
2023
Q1 		$259K Buy
1,711
+793
+86% +$161K ﹤0.01% 5587
2022
Q4 		$262K Sell
918
-1,447
-61% -$278K ﹤0.01% 5558
2022
Q3 		$530K Buy
2,365
+1,416
+149% +$601K ﹤0.01% 5241
2022
Q2 		$459K Buy
+949
New +$1.12M ﹤0.01% 5463

Other funds holding NUTX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PP
Pertento Partners London, United Kingdom $1.37B AUM 36.36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
TCM
Topline Capital Management Santa Monica, California $605M AUM 26.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
WC
Winmill & Co Rochester, New York $347M AUM 37.48% 1-Year Est. Return

Morgan Stanley's NUTX Position: Q1 2026 in Review

Morgan Stanley reduced its Nutex Health (NUTX) stake by 26% in Q1 2026, selling an estimated $1.86M and leaving 42,498 shares worth $4.04M. The position accounts for ﹤0.01% of the portfolio, ranked #4287.

Morgan Stanley first reported a position in NUTX in Q2 2022 and has held it in 15 quarters since. The position peaked at $12.5M in Q3 2025. 129 funds tracked by Wall St. Rank hold NUTX as of Q1 2026.

  • Morgan Stanley held 42,498 shares of Nutex Health worth $4.04M as of Q1 2026.
  • Morgan Stanley sold 15,142 Nutex Health shares in Q1 2026, an estimated $1.86M.
  • Nutex Health made up ﹤0.01% of Morgan Stanley's portfolio in Q1 2026, its #4287 holding.
  • Morgan Stanley first reported a position in Nutex Health in Q2 2022 and has held it in 15 quarters since.
  • Morgan Stanley's Nutex Health position peaked at $12.5M in Q3 2025.
  • 129 funds tracked by Wall St. Rank held Nutex Health as of Q1 2026.

Based on Morgan Stanley's 13F filing for Q1 2026, filed 15 May 2026.